|
HS Code |
174445 |
| Iupac Name | N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl]propane-1-sulfonamide |
| Molecular Formula | C17H12ClF2N3O3S |
| Molecular Weight | 427.82 g/mol |
| Appearance | Solid |
| Solubility | DMSO, DMF (predicted) |
| Storage Conditions | Store in a cool, dry place, away from light |
| Purity | Typically ≥98% (if purchased analytically) |
| Synonyms | No common synonyms |
| Chemical Class | Aromatic sulfonamides |
As an accredited N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a 1-gram amber glass vial with a tamper-evident cap and clearly labeled with its chemical name. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): Securely packed in safe chemical drums, fully utilizing container capacity for efficient bulk export and optimized transport. |
| Shipping | This chemical, N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide, is shipped in secure, leak-proof containers with appropriate hazard labeling. It is handled in compliance with chemical safety regulations, including temperature control and documentation, to ensure safe transport and integrity during shipping. Safety data sheet accompanies each shipment. |
| Storage | Store **N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide** in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerator). Avoid exposure to direct sunlight and incompatible materials such as strong oxidizers. Ensure proper labeling and handle with suitable personal protective equipment in a well-ventilated area. Keep away from heat sources and store per local chemical safety regulations. |
| Shelf Life | Shelf life: Stable for at least 2 years if stored in a cool, dry place, protected from light and moisture. |
|
Purity 98%: N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide with 98% purity is used in pharmaceutical intermediate synthesis, where it ensures high-yield product formation and minimal impurities. Melting Point 174°C: N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide with a melting point of 174°C is utilized in solid-state formulation processes, where thermal stability supports consistent crystallinity. Particle Size <10 μm: N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide with particle size less than 10 μm is applied in injectable formulations, where enhanced dissolution rates are achieved. Stability Temperature 60°C: N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide stable up to 60°C is used in high-temperature storage applications, where it maintains compound integrity without degradation. Molecular Weight 437.79 g/mol: N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide with a molecular weight of 437.79 g/mol is implemented in drug discovery assays, where accurate dosing and reproducible bioactivity are ensured. |
Competitive N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At our core, we focus entire years of development on molecules that hold up to the rigors of R&D and real-world scale-up. N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide is not just another intermediate—it has become a mainstay in pharmaceutical and agrochemical research labs because of its powerful blend of chemical stability, fine-tuned purity profiles, and real-world yield in the hands of technical staff. Many contract chemists and development teams report that, unlike earlier-generation carbonyl-linked analogues, products built from this compound reach their endpoint with fewer purification cycles. We see demand grow as teams realize that the integrity of the chlorinated pyrrolo-pyridine core holds up surprisingly well to modern coupling reactions, accelerating workups and saving valuable batch time.
Our own journey with this molecule taught us that chasing theoretical yields or chasing cost per kilogram means little if batch-to-batch reproducibility slips. Running hundreds of kilo-scale and small-pilot batches in stainless steel and glass reactors, our staff saw firsthand that micron-level control of moisture and a careful approach to amide bond formation preserves purity better than shortcutting with generalized reagents. This experience led us to a strict threshold: each lot passes HPLC, elemental, and spectroscopic checks targeting 98% min. assay, low ppm-inorganic residues, and sub-0.5% total related impurities. Color and appearance, though sometimes overlooked, reflect process history—slight beige to off-white is normal, and bright white signals overheating, which degrades the active core.
Each drum or poly-lined fiber carton leaves our facility as a tightly packed, free-flowing crystalline solid. Granulation checks in every batch prove especially useful for formulation scientists who value dust-free weighing and the ability to resource portions directly for inline synthesis, especially at the 100 g to 100 kg scale. Direct feedback from partner labs—especially those working at the scale-up and process development interface—confirmed for us that fine, consistent grain size makes weighing less wasteful and mechanical transfer less prone to loss.
Process chemists and bench scientists typically put this molecule to work in synthesis trees where they need high selectivity at sensitive steps. Typical use cases cover kinase inhibitor scaffolds and key fragments for next-generation oncology and anti-inflammatory agents. The inherent reactivity of the difluoro-phenyl group—paired with a carefully positioned sulfonamide—lets teams fast-track Suzuki, Buchwald-Hartwig, and amide coupling protocols. During dozens of technical consultations, we heard chemistry leads express relief at the absence of unexpected hydrolytic breakdown or isomer formation, especially in conditions pushing the boundaries of base strength or temperature.
Medicinal chemistry demands not only clean starting points but scalability, so we never ignore what it takes for a gram-scale proof of concept to survive all the way to cGMP manufacture. Cleaner conversions downstream prevent backlogs in QA and QC, and this translates directly into time saved. Several of our customer partners point out that switching to this compound from similar sulfonamide alternatives led to a 10-20% overall reduction in downstream purification steps, especially where IP-sensitive fragments are involved.
After years in the plant, we have seen how overconfidence with storage ruins more material than almost any other factor. The stability of N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide meets ICH guidelines for ambient and controlled-cold storage, with a shelf life extending beyond 24 months under low-light, low-humidity conditions. Still, our own experience—backed up by partner QA results—shows that clumping and minor discoloration occur if users leave containers open too long in humid conditions. As a manufacturer, we package every shipment airtight, with desiccant, and urge users to avoid repacking unless absolutely required. These are not instructions for the sake of policy, but habits formed from seeing avoidable spoilage cut deeply into analytical repeatability and cost.
Handling on the shop floor presents few issues, since dust control and electrostatic buildup both register near the low end for compounds of this class. Regular cleaning with HEPA-filtered vacuums suffices for most spills. Teams working with solvent metering or automated weighing appreciate not fighting agglomerated solids or built-up static on surfaces, which is common with lesser-refined intermediates in the same structural family.
Direct experience with related intermediates revealed that many struggle with batch consistency and compatibility—particularly those lacking both the chlorinated pyrrolo-pyridine and the difluoro-phenyl backbone. Some analogues, especially those with broader structural flexibility, break down unpredictably during aggressive conditions required for late-stage synthesis, and inferior-grade materials introduce more byproduct peaks. We track impurity trends after every process change, and the track record for this sulfonamide surpasses every similar intermediate we have put through our QC labs.
Process audits in our facility revealed the value of a tightly locked-in crystal habit. Among hundreds of processed kilograms, only a handful of cases ever produced “off-spec” lots—almost always linked to supplier grade of starting fluorinated aromatics. In contrast, analogues with looser specifications on positional fluorination or sulfonamide substitution foster more inconsistent reactivity. These observations hold especially true on plant lines aiming for exacting regulatory standards.
We used to employ sulfonamides with single fluorination, thinking the simplicity meant smoother downstream chemistry. Several scale campaigns showed persistent side reactions unless both ortho- and para-positions were electron-deficient via fluorine. Seeing those trends reflected in customer project notebooks made the case for committing to this more robust, doubly-fluorinated structure. It became clear the market demanded reliability from gram-lot pilot batches through multi-kilogram production—an area where our N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide demonstrates a clear edge.
Working in an environment where advancing safety goals never take a back seat, our teams put serious effort into minimizing operator exposure and limiting waste generation. The sulfonamide hangs on to its minimal volatility and nonhygroscopic nature across a range of process conditions. Plant staff record almost no inhalational risk or sensitivity reactions—a rarity for nitrogen- and halogen-rich molecules. Environmental checkpoints at our facility log single-digit ppm levels for residual materials in wastewater, a reflection of efficient filtration and recycling methods. Waste classification for this product avoids the more restrictive regulations that dog many aromatic amides, due in part to the balanced reactivity and isolation protocols at our site.
Process safety audits show that runaway risk under standard thermal exposure remains negligible. Heat aging and accelerated stability tests done at our internal labs—and confirmed in at least two customer pilot facilities—demonstrate little risk of decomposition or hazardous volatile byproduct formation at the typical 20-45°C lab and plant range. This chemical avoids the propensity of similar halogenated aromatics to trigger exothermic decomposition when pushed, allowing for steadier temperature ramping during scale-up.
Running a manufacturing line for years gives us perspective that you cannot source from catalog descriptions. Process improvements come from listening to chemists struggling with throughput bottlenecks, not just from reviewing published synthesis routes or generic literature. Our team interacts directly with scientists troubleshooting mixture complexity and stepwise yields. Listening to details about how a sticky filtration or recrystallization messes with timelines drives our incremental improvements in workup protocols and packaging specs.
Collaboration with customer QA and process optimization teams led to many gains—a notable one came from adjusting our final solvent removal step, which improved batch uniformity and made material easier to handle on automated dosing lines. Several partner labs contributed hard-earned insight on solvent carryover, suggesting modified drying approaches that our plant adopted. Process transparency and direct lines of feedback prevent repetition of old mistakes. This two-way street, built on joint technical goals, constantly sharpens the specifications and process controls we apply.
We own the production process from raw feedstock to packaged intermediate. This full control helps insulate users from the fluctuations in quality that often spring up in distributed supply models. Several of our contract partners pointed out they moved to our direct supply line after repeated problems with off-grade or mismatched batches, which threw development campaigns off schedule and hiked analytical costs.
Our teams understand that once delivered, the way end users access and transfer the material sets the tone for downstream reliability. Having encountered plenty of poorly packed or contaminated lots over the years, we worked directly with technical teams to standardize drum lining materials, desiccant insertion, and traceability tagging. This approach may sound basic, but it prevents the headaches many encounter dealing with fragmentation and contamination introduced during third-party repacking. Clean in, clean out—batch after batch.
Every year, tightening regulatory and competitive environments demand cleaner chemistry, shorter lead times, and less guesswork on traceability. Where once a rough-and-ready intermediate sufficed, project teams now navigate global scrutiny and strict release testing. The rush to new drug candidates and ag-chem compounds with exacting specs forced us to revisit all legacy processes—our commitment to this molecule’s performance has made us adjust crystallization protocols, revisit analytical methods, and keep a zero-tolerance approach for lot mixing.
Feedback loops from global sites now influence every campaign, and we dedicate team cycles to supporting scale transfer, process troubleshooting, and custom spec development where projects warrant. Our investment in in-house analytical capacity—ranging from NMR to advanced chromatographic mapping—ensures users can access lot snapshots beyond minimal COA standards. Technical staff routinely flag lots that show any sign of deviation, and every flagged batch triggers a full process review. This direct accountability to end users remains a non-negotiable standard.
Producing N-[3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluoro-phenyl]propane-1-sulfonamide has taught us the value of sticking to proven processes while staying open to real-world feedback. Years spent resolving the challenges of unevenly fluorinated structures, variable crystal habits, and recurring impurity spikes set the groundwork for the reliable delivery teams count on today. We won’t shift away from what hands-on experience and data tell us. Those who work with this intermediate in pursuit of innovative medicines and crop solutions should find it meets the demands of modern chemistry, both in the plant and at the bench.